Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
Option Care Health, Inc. provides home and alternate-site infusion services for patients with acute and chronic conditions across the United States. The company operates in infusion services and reports developments tied to clinical service delivery, national provider relationships, and the economics of its care model.
Recurring news for OPCH includes quarterly and full-year financial results, guidance updates, operating cash flow, share repurchase activity, credit facility changes, and presentations at health care investor conferences. Company updates also address capital allocation and management commentary related to revenue growth and profitability in home and alternate-site infusion care.
Option Care Health, the largest independent provider of home and alternate site infusion services, reported strong financial results for Q2 2021. Net revenue reached $860.3 million, a 16.1% increase year-over-year. Gross profit rose to $199.0 million, equating to 23.1% of net revenue, with net income of $31.8 million or $0.18 per share, marking a turnaround from a net loss in Q2 2020. Adjusted EBITDA grew by 33.3% to $72.8 million, and cash flow from operations improved to $73.7 million. The company also completed an acquisition of BioCure's assets for $18.9 million.
Option Care Health (Nasdaq: OPCH) has appointed Dr. Seema Kumbhat as its new Chief Medical Officer. In her role, she will oversee clinical strategies, operations, quality improvement, and regulatory compliance. Dr. Kumbhat has a strong background, previously serving as Senior Vice President and Regional Medical Officer at Fresenius Kabi, and has held positions at major healthcare organizations. CEO John Rademacher expressed confidence in her ability to enhance patient care and clinical outcomes as the company continues to differentiate its infusion services.
On July 21, 2021, AlayaCare and Option Care Health (Nasdaq: OPCH) announced a technology collaboration to enhance software for alternate site infusion therapy. This partnership aims to improve patient engagement and care delivery through advanced automation and data capture tools. Option Care Health currently utilizes AlayaCare's software to manage clinical resources. Both companies are focused on enhancing patient experiences and achieving superior clinical outcomes through this strategic collaboration.
Option Care Health (NASDAQ: OPCH) announced it will release its second quarter results for the period ending June 30, 2021, on August 3, 2021, prior to the market opening. The management team will conduct a conference call at 8:30 a.m. E.T. on the same day to discuss the results. The call will be accessible via phone or live audio webcast, with a replay available shortly after for approximately 90 days. Option Care Health is the largest independent provider of home and alternate site infusion services in the United States, employing over 5,000 individuals.
Option Care Health announced an underwritten public offering of 15,000,000 shares at $20.00 per share, increasing from an initial 10,000,000 shares. The offering, led by Goldman Sachs & Co. LLC, is expected to close on June 10, 2021, subject to customary conditions. The Selling Stockholder will reduce its ownership from 47.3% to 38.9% post-offering (or 37.7% if the underwriter's option is exercised). The company will not receive proceeds from this offering.
Option Care Health (NASDAQ: OPCH) announced the sale of 10,000,000 shares of its common stock by an affiliate of Madison Dearborn Partners, representing approximately 5.6% of current outstanding shares. The underwriter, Goldman Sachs & Co. LLC, has a 30-day option to purchase an additional 1,500,000 shares. After this offering, the selling stockholder's interest will decrease from 47.3% to 41.7% (or 40.9% with the additional shares). The company will not receive any proceeds from the offering.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced that CEO John C. Rademacher and CFO Mike Shapiro will participate in two major investor conferences. They will present at the William Blair 41st Annual Growth Stock Conference on June 2, 2021, at 3:00 p.m. ET, and the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021, at 1:20 p.m. ET. Webcast links for both events will be available on their investor relations website.
Option Care Health (Nasdaq: OPCH) reported strong financial results for Q1 2021, with net revenue of $759.2 million, an increase of 7.6% from the previous year. Gross profit rose to $165.5 million, representing 21.8% of net revenue. The net loss narrowed to $2.9 million, or $0.02 per share, improving from a loss of $19.9 million in Q1 2020. Adjusted EBITDA surged 30% to $52.2 million. The company also announced the retirement of its second lien debt and an acquisition of chronic therapy assets for $18.5 million.
Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., will present at the Bank of America 2021 Health Care Conference on May 11, 2021, at 8:45 a.m. EDT. CEO John Rademacher and CFO Mike Shapiro are scheduled to represent the company during this event. With over 5,000 employees, including around 2,900 clinicians, Option Care Health focuses on enhancing care standards for patients with both acute and chronic conditions across all 50 states.
Option Care Health (NASDAQ: OPCH) announced its first-quarter earnings report will be released on May 6, 2021, before market opening. The management team will host a conference call at 8:30 a.m. E.T. to discuss the results. Option Care Health is the largest independent provider of home and alternate site infusion services in the U.S., employing over 5,000 individuals, including about 2,900 clinicians. The company aims to enhance care standards for patients with both acute and chronic conditions across all 50 states.